Karyopharm Therapeutics Inc. Common Stock — Institutional Ownership
Which tracked institutions hold KPTI, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
11
Funds holding
$7959422
Total value held
Buying
8 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Goldman Sachs Group Inc | $5278015 | 947579 | — | NEW BUY |
| 2 | Blackrock, Inc. | $1364087 | 244899 | -2659 | -1.07% |
| 3 | State Street Corp | $449733 | 80742 | +21800 | +36.99% |
| 4 | Royal Bank Of Canada | $336000 | 60399 | — | NEW BUY |
| 5 | Northern Trust Corp | $214757 | 38556 | +9533 | +32.85% |
| 6 | Bank Of America Corp /De/ | $108459 | 19472 | -28616 | -59.51% |
| 7 | Morgan Stanley | $103436 | 18570 | +9712 | +109.64% |
| 8 | Bank Of New York Mellon Corp | $63490 | 11399 | +312 | +2.81% |
| 9 | Barclays Plc | $41352 | 7424 | — | NEW BUY |
| 10 | Amalgamated Financial Corp. | $86 | 11722 | — | NEW BUY |
| 11 | Citigroup Inc | $7 | 1 | -512 | -99.81% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.